Characterization of Adrenal Masses by Using FDG PET: A Systematic Review and Meta-Analysis of Diagnostic Test Performance
- 1 April 2011
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 259 (1), 117-126
- https://doi.org/10.1148/radiol.11100569
Abstract
Purpose: To perform a systematic review and meta-analysis of published data to determine the diagnostic utility of adrenal fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) for distinguishing benign from malignant adrenal disease. Materials and Methods: Data on FDG PET assessment in MEDLINE and other electronic databases (from inception to November 2009) and in subject matter-specific journals were evaluated and compared with histologic diagnoses and/or established clinical and imaging follow-up results. Methodologic quality was assessed by using Quality Assessment of Diagnostic Accuracy Studies criteria. Bivariate random-effects meta-analytical methods were used to estimate summary and subgroup-specific sensitivity, specificity, and receiver operating characteristic curves and to investigate the effects of study design characteristics and imaging procedure elements on diagnostic accuracy. Results: A total of 1391 lesions (824 benign, 567 malignant) in 1217 patients from 21 eligible studies were evaluated. Qualitative (visual) analysis of 841 lesions (in 14 reports) and quantitative analyses based on standardized uptake values (SUVs) for 824 lesions (in 13 reports) and standardized uptake ratios (SURs) for 562 lesions (in eight reports) were performed. Resultant data were highly heterogeneous, with a model-based inconsistency index of 88% (95% confidence interval [CI]: 79%, 98%). Mean sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio values for differentiating between benign and malignant adrenal disease were 0.97 (95% CI: 0.93, 0.98), 0.91 (95% CI: 0.87, 0.94), 11.1 (95% CI: 7.5, 16.3), 0.04 (95% CI: 0.02, 0.08), and 294 (95% CI: 107, 805), respectively, with no significant differences in accuracy among the visual, SUV, and SUR analyses. Conclusion: Meta-analysis of combination PET-computed tomography (CT) reports revealed that FDG PET was highly sensitive and specific for differentiating malignant from benign adrenal disease. Diagnostic accuracy was not influenced by the type of imaging device (PET vs PET/CT), but specificity was dependent on the clinical status (cancer vs no cancer). (C) RSNA, 2011This publication has 52 references indexed in Scilit:
- Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging CharacterizationRadiology, 2008
- The Incidental Adrenal Mass on CT: Prevalence of Adrenal Disease in 1,049 Consecutive Adrenal Masses in Patients with No Known MalignancyAmerican Journal of Roentgenology, 2008
- Imaging of Adrenal Incidentalomas: Current StatusAmerican Journal of Roentgenology, 2002
- Adrenal Masses: Characterization with Combined Unenhanced and Delayed Enhanced CTRadiology, 2002
- State-of-the-Art Adrenal ImagingRadioGraphics, 2001
- Characterization of Indeterminate (Lipid-poor) Adrenal Masses: Use of Washout Characteristics at Contrast-enhanced CTRadiology, 2000
- Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature.American Journal of Roentgenology, 1998
- CT time-attenuation washout curves of adrenal adenomas and nonadenomas.American Journal of Roentgenology, 1998
- Adrenal masses: characterization with delayed contrast-enhanced CT.Radiology, 1997
- Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.American Journal of Roentgenology, 1995